Japan Nobel winner vows to continue research to 'save more patients than ever'

October 1, 2018
Credit: CC0 Public Domain

The Japanese scientist who Monday won the Nobel Prize for medicine vowed to continue his cancer treatment work to help as many sufferers as possible, saying treating patients gave him more pleasure than any award.

"I want to continue my research ... so that this immune therapy will save more cancer patients than ever," Tasuku Honjo told reporters at Kyoto University where he is based.

He described his feelings of "immense joy" when people told him they had recovered from severe illnesses due to his work.

He said a member of his golf club, whom he did not know well, came up to him one day and thanked him, saying: "Thanks to your medicine. I had lung cancer and I thought I was playing my last round of golf, but now I am able to play golf again."

"When you hear things like that, there is no greater happiness. I have never been happier than that. Honestly, no award can replace that. I felt it was enough," said Honjo.

"On top of that, I am receiving such an award. I really feel I am a fortunate person."

Honjo said he heard the news of his award while he was discussing academic papers with colleagues and it came "completely out of the blue."

"Of course, I was very happy, delighted at the same time, but shocked."

During the press conference, Honjo took a call from Prime Minister Shinzo Abe, who congratulated the scientist, saying he was "so proud as a fellow Japanese."

Abe said someone he knew was saved by treatment resulting from the professor's research.

"The professor's achievement has given rays of hope to many cancer patients," said Abe.

Honjo won the prize, along with US scientist James Allison, for research into how the body's natural defences can fight cancer.

But he said he also has ambitions to go round the golf course in the same number of shots at his age.

"I am 76 now. My biggest goal is to hit 76 in golf."

Explore further: US, Japan duo win Nobel Medicine Prize for cancer therapy

Related Stories

US, Japan duo win Nobel Medicine Prize for cancer therapy

October 1, 2018
Two immunologists, James Allison of the US and Tasuku Honjo of Japan, won the 2018 Nobel Medicine Prize for research into how the body's natural defences can fight cancer, the jury said on Monday.

US, Japanese immunologists awarded Tang Prize for cancer quest

June 19, 2014
An American and a Japanese immunologist were Thursday named joint recipients of the Tang Prize, touted as Asia's version of the Nobels, for their contributions in the fight against cancer.

Three scientists share $500,000 prize for work on cancer therapy

August 15, 2018
Tumors once considered untreatable have disappeared and people previously given months to live are surviving for decades thanks to new therapies emerging from the work of three scientists chosen to receive a $500,000 medical ...

Modest Nobel laureate says Japan deserves his prize

October 8, 2012
Japanese stem cell pioneer Shinya Yamanaka responded modestly after winning the Nobel prize for medicine Monday, saying his country really deserves the award.

Recommended for you

Immunotherapy combo not approved for advanced kidney cancer patients on the NHS

December 14, 2018
People with a certain type of advanced kidney cancer will not be able to have a combination of two immunotherapy drugs on the NHS in England.

New drug seeks receptors in sarcoma cells, attacks tumors in animal trials

December 13, 2018
A new compound that targets a receptor within sarcoma cancer cells shrank tumors and hampered their ability to spread in mice and pigs, a study from researchers at the University of Illinois reports.

Surgery unnecessary for many prostate cancer patients

December 13, 2018
Otherwise healthy men with advanced prostate cancer may benefit greatly from surgery, but many with this diagnosis have no need for it. These conclusions were reached by researchers after following a large group of Scandinavian ...

Combining three treatment strategies may significantly improve melanoma treatment

December 12, 2018
A study by a team led by a Massachusetts General Hospital (MGH) investigator finds evidence that combining three advanced treatment strategies for malignant melanoma—molecular targeted therapy, immune checkpoint blockade ...

Researchers use computer model to predict prostate cancer progression

December 12, 2018
An international team of cancer researchers from Denmark and Germany have used cancer patient data to develop a computer model that can predict the progression of prostate cancer. The model is currently being implemented ...

An integrated approach to finding new treatments for breast cancer

December 12, 2018
Unraveling the complexity of cancer biology can lead to the identification new molecules involved in breast cancer and prompt new avenues for drug development. And proteogenomics, an integrated, multipronged approach, seems ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.